Fibrinolytic therapy is a medical treatment designed to dissolve blood clots and restore normal blood flow in conditions such as acute ischemic stroke, myocardial infarction, and deep vein thrombosis. It involves the use of fibrinolytic agents, such as tissue plasminogen activators (tPA), which work by activating plasminogen to plasmin, an enzyme that breaks down fibrin—the main component of blood clots

The Premature Ejaculation Treatment Market includes all products and therapies geared for the treatment of PE – this is a condition under which a man ejaculates earlier than desired during intercourse, thus causing personal distress or reduced sexual pleasure. This market comprises medicines such as the drugs used to treat the condition, topical products, behavioural therapy, devices, and any other product that might assist an individual with the condition.